Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$4,005,857
+$465,990 QoQ
Shares Held
15,919
-2.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#1,454
of 4,153 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Calamos Wealth Management LLC holds $79,224,350 across 11 Drug Manufacturers - General names. ABBV ranks #3 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
31,177 | $37,394,632 | |
| 2 | JNJ |
Johnson & Johnson
|
118,126 | $30,000,460 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
15,919 | $4,005,857 | |
| 4 | MRK |
Merck & Co., Inc.
|
20,811 | $2,674,213 | |
| 5 | PFE |
Pfizer Inc
|
65,212 | $1,570,304 | |
| 6 | AMGN |
Amgen Inc
|
2,408 | $871,984 | |
| 7 | AZN |
Astrazeneca PLC
|
4,208 | $797,920 | |
| 8 | NVS |
Novartis AG
|
4,898 | $767,614 |
All Filings in ABBV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,005,857 | 15,919 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $3,539,867 | 16,276 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $3,398,788 | 14,875 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $3,410,352 | 14,729 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $1,564,962 | 8,431 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,697,950 | 8,104 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,609,962 | 9,060 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $1,748,092 | 8,852 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,399,431 | 8,159 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,588,640 | 8,724 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,652,910 | 10,666 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $1,787,825 | 11,994 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $1,564,888 | 11,615 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $1,791,318 | 11,240 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,661,512 | 10,281 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $1,382,094 | 10,298 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $1,879,732 | 12,273 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,978,066 | 12,202 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $1,240,805 | 9,164 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $997,905 | 9,251 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $1,044,623 | 9,274 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $490,344 | 4,531 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $364,417 | 3,401 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $204,084 | 2,330 | Shares | Sole | 2020-10-26 | |
| No filing history on record for this holder in this stock. | ||||||